BESPONSA (inotuzumab ozogamicin IV) 

OFFICE ADMINISTRATION

Indications for Prior Authorization:

  • Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)

Patients must meet the following criteria for the indication(s) above:

  • Prescribed by an oncologist, AND
  • Patient is 18 years or older, AND
  • Confirmed relapse or refractory Philadelphia chromosome positive ALL who are TKI-intolerant/refractory (B-cell acute lymphoblastic leukemia (B-ALL)), OR relapsed or refractory Philadelphia chromosome-negative ALL (B-ALL)

Dosing:

  • Pre-medicate before each dose
  • First cycle:
    • 1.8 mg/m2 , administered as 3 divided doses on Day 1 (0.8 mg/m2), Day 8 (0.5 mg/m2), and Day 15 (0.5mg/m2)
    • Cycle 1 is 3 weeks in duration but may extend to 4 weeks if the patient achieves a complete remission (CR) or complete remission with incomplete hematologic recovery (CRi), and/or to allow recovery from toxicity
  • Subsequent Cycles:
    • If CR or CRi is achieved: The recommended total dose is 1.5 mg/m2 per cycle, administered as 3 divided doses on Day 1 (0.5 mg/m2), Day 8 (0.5 mg/m2), and Day 15 (0.5 mg/m2). Subsequent cycles are 4 weeks in duration
    • If CR or CRi is not achieved: The recommended total dose is 1.8 mg/m2 given as 3 divided doses on Day 1 (0.8 mg/m2), Day 8 (0.5 mg/m2), and Day 15 (0.5 mg/m2). Subsequent cycles are 4 weeks in duration. Treatment should be discontinued if CR or CRi is not achieved within 3 cycles
  • Hematooietic stem cell transplant (HSCT) patients: The recommended duration is 2 cycles. A 3rd cycle may be considered for those who do not achieve CR or CRi and minimal residual disease (MRD) negativitiy after 2 cycles
  • Patients not proceeding to HSCT: Additional cycles of treatment, up to a maximum of 6 cycles, may be administered

Approval:

  • Initial approval: 1 cycle
  • First renewal: 1 or 2 cycles (depending if the patient is to proceed to HSCT or not)
  • Subsequent renewal: 1 more approval up to a maximum of 6 total cycles if the patient has achieved CR or CRi
  • Total maximum allowed cycles: 6 cycles

Last review date: September 4, 2018

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone